PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis
Open Access
- 8 March 2022
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 7 (5)
Abstract
Systemic sclerosis (SSc) is a chronic, multisystem orphan disease with a highly variable clinical course, high mortality rate, and a poorly understood complex pathogenesis. We have identified an important role for a subpopulation of monocytes and macrophages characterized by surface expression of the scavenger receptor macrophage receptor with collagenous structure (MARCO) in chronic inflammation and fibrosis in SSc and in preclinical disease models. We show that MARCO + monocytes and macrophages accumulate in lesional skin and lung in topographic proximity to activated myofibroblasts in patients with SSc and in the bleomycin-induced mouse model of SSc. Short-term treatment of mice with a potentially novel nanoparticle, poly(lactic- co -glycolic) acid (PLG), which is composed of a carboxylated, FDA-approved, biodegradable polymer and modulates activation and trafficking of MARCO + inflammatory monocytes, markedly attenuated bleomycin-induced skin and lung inflammation and fibrosis. Mechanistically, in isolated cells in culture, PLG nanoparticles inhibited TGF-dependent fibrotic responses in vitro. Thus, MARCO + monocytes are potent effector cells of skin and lung fibrosis and can be therapeutically targeted in SSc using PLG nanoparticles.Keywords
Funding Information
- Norges Idrettshøgskole (1 R21 AR073371-01)
- Scleroderma Foundation (A Novel Therapy For Scleroderma by Biodegradable Nanoparticles)
This publication has 65 references indexed in Scilit:
- Macrophage biology in development, homeostasis and diseaseNature, 2013
- Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunitiesNature Reviews Rheumatology, 2011
- Vascular Changes in Bleomycin-Induced SclerodermaInternational Journal of Rheumatology, 2011
- Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Regulatory T cells (CD4+CD25brightFoxP3+) expansion in systemic sclerosis correlates with disease activity and severityCellular Immunology, 2010
- Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosisArthritis & Rheumatism, 2008
- B cell infiltration in systemic sclerosis–associated interstitial lung diseaseArthritis & Rheumatism, 2007
- A Murine Scavenger Receptor MARCO Recognizes Polystyrene NanoparticlesToxicological Sciences, 2007
- User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliabilityNeuroImage, 2006
- Animal Model of Sclerotic Skin. I: Local Injections of Bleomycin Induce Sclerotic Skin Mimicking SclerodermaJournal of Investigative Dermatology, 1999